Algo version: 0.98b
SAVAW is listed at the NASDAQ Exchange
SAVAW [SAVAW]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is SAVAW stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Cassava Sciences, Inc. 10 years ago, but if you had invested on Thursday 4th of January 2024 when the price was $3.17, you would have made a loss of $-3.14 per share or -99.05%

Yes, the average daily trading liquidity for Cassava Sciences, Inc. is $2.06 million. You should therefore be able to get in and out of your positions relatively fast.

Cassava Sciences, Inc. has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Cassava Sciences, Inc. to be low [0 out of 1]